Experimental browser for the Atmosphere
The FDA's shift away from animal testing could be a windfall for makers of nonanimal models like organ chips, organoids, and computer simulations. But there will be challenges, especially given the FDA's outlined 3-5-year timeline. @cenmag.bsky.social #chemsky #biosky cen.acs.org/pharmaceutic...
Apr 30, 2025, 4:50 PM
{
"text": "The FDA's shift away from animal testing could be a windfall for makers of nonanimal models like organ chips, organoids, and computer simulations. But there will be challenges, especially given the FDA's outlined 3-5-year timeline. @cenmag.bsky.social #chemsky #biosky\n\ncen.acs.org/pharmaceutic...",
"$type": "app.bsky.feed.post",
"embed": {
"$type": "app.bsky.embed.external",
"external": {
"uri": "https://cen.acs.org/pharmaceuticals/drug-development/FDAs-shift-animal-testing-opens/103/web/2025/04",
"thumb": {
"$type": "blob",
"ref": {
"$link": "bafkreiclzck2lqvajbsuhchfiw2ztv35ip4znsrkpd6visdr4a7w5n6cjm"
},
"mimeType": "image/jpeg",
"size": 357359
},
"title": "FDA’s shift from animal testing opens doors for organoid makers",
"description": "New policy could be a windfall for makers of nonanimal models"
}
},
"langs": [
"en"
],
"facets": [
{
"$type": "app.bsky.richtext.facet",
"index": {
"byteEnd": 251,
"byteStart": 232
},
"features": [
{
"did": "did:plc:u4u4yeik2uube2g6ov7wr35p",
"$type": "app.bsky.richtext.facet#mention"
}
]
},
{
"index": {
"byteEnd": 260,
"byteStart": 252
},
"features": [
{
"tag": "chemsky",
"$type": "app.bsky.richtext.facet#tag"
}
]
},
{
"index": {
"byteEnd": 268,
"byteStart": 261
},
"features": [
{
"tag": "biosky",
"$type": "app.bsky.richtext.facet#tag"
}
]
},
{
"index": {
"byteEnd": 297,
"byteStart": 270
},
"features": [
{
"uri": "https://cen.acs.org/pharmaceuticals/drug-development/FDAs-shift-animal-testing-opens/103/web/2025/04",
"$type": "app.bsky.richtext.facet#link"
}
]
}
],
"createdAt": "2025-04-30T16:50:18.536Z"
}